News

Lilly and Gate Bioscience Partner to Advance Next-Generation Molecular Gate Medicines

July 2025  Gate Bioscience, a biotechnology innovator specializing in molecular gates a novel class of small-molecule drugs designed to remove… Read More

3 days ago

USCDI v6 Launches with New Features to Advance Healthcare Interoperability

July 24, 2025 – The Office of the Assistant Secretary for Technology Policy (ASTP) has announced the release of United… Read More

3 days ago

Small-Scale Bioreactors Market Growing Research and Development Activities Propel Asia-Pacific’s

Asia-Pacific is poised to become the fastest-growing region in the small-scale bioreactors market over the coming years, driven by several… Read More

6 days ago

Which Factors are Driving the Neurostimulation Devices Market in North America?

North America continues to dominate the global neurostimulation devices market, holding a significant 60% share in 2024. Several key factors… Read More

6 days ago

AAVnerGene and Klotho Neurosciences Join Forces to Revolutionize Gene Therapy

AAVnerGene Inc., an innovative biotech company based in Rockville, MD, known for its cutting-edge AAV tissue-targeted delivery and manufacturing technologies,… Read More

6 days ago

Hengrui and IDEAYA Biosciences to Present Breakthrough Data at IASLC 2025 World Conference on Lung Cancer

Jiangsu Hengrui Pharmaceuticals Co., Ltd. and IDEAYA Biosciences, Inc. are set to showcase their groundbreaking research at the IASLC 2025… Read More

7 days ago

QIAGEN Expands NGS Portfolio with Innovative Long-Read Panels

QIAGEN has launched its new QIAseq xHYB long-read panels, a cutting-edge solution designed to explore the complexities of genomically diverse… Read More

7 days ago

Kansai and Alloy Join Forces to Accelerate Japan’s Life Science Startup Ecosystem

Kyoto, Japan  July 2025  A groundbreaking collaboration has been formed between Kansai Startup Academia Coalition (KSAC), led by Kyoto University,… Read More

7 days ago

AI in Clinical Trials for Drugs Europe Breakthrough Moment

Europe is on the brink of a revolution in drug development, powered by Artificial Intelligence (AI). As healthcare systems strive… Read More

1 week ago

AusperBio Secures China CDE Approval to Advance AHB-137 into Phase 3 Clinical Trial for Chronic Hepatitis B

July 2025  Beijing, China: AusperBio Therapeutics Inc. and Ausper Biopharma Co., Ltd. (collectively known as AusperBio) have received the green… Read More

1 week ago